Participate in Research

Clinical Trial for People with Diabetic Peripheral Neuropathic Pain (DPNP)
Protocol: STUDY00007155
Full Title
A multicentre randomized, double-blind, placebo-controlled Phase 2a study to evaluate efficacy, safety, tolerability, pharmacokinetics and target engagement of GSK3858279 in adult patients with Chronic Diabetic Peripheral Neuropathic Pain (DPNP)
Description
The University at Buffalo (UB) Department of Medicine is looking for adults diagnosed with diabetic peripheral neuropathic pain (DPNP) for a clinical trial. People will DPNP feel pain that is caused by damage to their nerves due to diabetes. The goal of the study is to investigate the safety and effectiveness of a new study drug that may treat DPNP.

Participants will be enrolled in this study for 32 weeks. They will either receive the study drug or a placebo, which looks like the study pill but has no active medication. Participants will be randomly assigned (which happens by chance, like flipping a coin) to one of 3 groups: 2 groups will receive different doses of the study drug and the final group will receive the placebo. They will take the study drug/placebo for 12 weeks and then complete a 15-week follow-up period. Participants will complete physical exams, lab tests, and surveys and rate their pain in an e-diary. They will receive $75 for each completed study visit.
Compensation: Yes
?
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Eligibility
Adults aged 18 to 75 years old Have been diagnosed with diabetic peripheral neuropathic pain (DPNP)
Age Group: Adults
Principal Investigator: AJAY CHAUDHURI
Contact(s)
HUSAM GHANIM
ghanim@buffalo.edu
+1 716-881-8924
Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions